Analysis of mRNA Therapeutics and Vaccines: Analytical approaches must keep pace to ensure the identity, safety, and efficacy of evolving mRNA candidates.
| Publicado en: | Pharmaceutical Technology Europe Vol. 34; no. 2; pp. 9 - 14 |
|---|---|
| Autor principal: | |
| Formato: | pictorial tables/charts Journal Article |
| Publicado: |
MJH Life Sciences
Feb2022
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=155423685&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 155423685 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 17537967 5NG jtl: Pharmaceutical Technology Europe issn: 17537967 maglogo: N pubinfo: dt: Feb2022 vid: 34 iid: 2 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 155423685 155423685 155423685 155423685 ppf: 9 ppct: 5 formats: fmt: @attributes: type: P tig: atl: Analysis of mRNA Therapeutics and Vaccines: Analytical approaches must keep pace to ensure the identity, safety, and efficacy of evolving mRNA candidates. aug: au: Challener, Cynthia A. sug: subj: RNA, Messenger COVID-19 Vaccines Safety Vaccine Efficacy Nanoparticles Drug Development Microscopy, Electron Utilization Polymerase Chain Reaction Sequence Analysis Technology, Medical Trends pubtype: Trade Publication doctype: pictorial tables/charts Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|